Lp(a): The Heart Risk Most Blood Tests Don’t Check

Julien was lean, trained consistently, and received a clean cholesterol panel every year. His GP had no concerns. By every standard health check measure, his heart looked exactly where it should be.

But one number — never included in any health screen he had received — was sitting at more than twice the safe upper limit.

This is not a rare story. We see it at TSquared Health with a regularity that should change how preventive medicine is practised. A person doing everything right — eating carefully, exercising, maintaining a healthy weight — carries a genetically elevated heart risk that no routine health screen in Singapore routinely measures. They may carry it for their entire life without knowing.

The marker is called Lp(a). And it may be the most important cardiovascular risk factor that most people have never heard of.

What Lp(a) Actually Is

Think of LDL cholesterol as a truck that carries fat and cholesterol through your bloodstream. Lp(a) is a similar truck — but with an extra passenger on board that causes specific and additional problems.

LDL builds up in artery walls as plaque. Lp(a) does the same. But the extra passenger also makes blood clots harder for your body to dissolve. This means elevated Lp(a) is working against you in two ways at once: building up in your arteries, and making clots stick around longer than they should. Standard screening catches neither.

The most important piece: Lp(a) is determined by your genetics. Unlike LDL, which can be lowered through diet, exercise, and medication, Lp(a) is largely set by your DNA. Roughly 1 in 5 people globally carry Lp(a) at levels that meaningfully raise cardiovascular risk — not because of anything they eat or how much they exercise, but because of their genes.

Population carrying elevated Lp(a)

1 in 5

Levels above 50 mg/dL are associated with a two- to threefold increase in cardiovascular event risk. Most will never be tested.

Most labs flag Lp(a) as high risk above 50 mg/dL. In Julien’s case, his level was more than 2.5 times that threshold. His cholesterol panel, his annual health check, his GP’s review — none had captured it. Not because of a mistake. Because the test was never ordered.

An Ancient Molecule in a Modern World

Lp(a) has been part of the human genome for millions of years. It exists at roughly 20% population prevalence because, for most of human history, it was a genuine survival advantage.

The property that makes Lp(a) a cardiovascular risk factor today — it slows down your body’s natural ability to break down blood clots — would have been life-saving in a world where the main cause of early death was physical trauma, not arterial disease. A molecule that keeps clots intact helps a person survive a wound that might otherwise prove fatal from blood loss.

People with elevated Lp(a) may be descendants of individuals who survived injuries that others did not. The trait persisted because it worked.

“It is not a calorie problem. It is a cortisol problem that has become self-sustaining.”

Today, the risk is not blood loss. It is long-term inflammation and stress on arteries. The property that once protected now builds up plaque and sustains clots in places they should not be.

This matters because elevated Lp(a) is not a sign that something is wrong with your body. It is your genome doing what it was built to do, in a world it was never designed for. The right response is not to treat a defect. It is to understand the mismatch and manage around it.

Why Most Blood Tests Don’t Measure It

The standard cholesterol panel — the one most Singaporeans receive every year — was designed in the 1950s and 1960s. Total cholesterol. LDL. HDL. Triglycerides. At the time, Lp(a) had not been fully characterised as an independent heart risk. The system was built around what medicine understood then.

The result is that most Singaporean health screening in 2026 is still asking questions that are decades out of date.

There is also a practical reason Lp(a) is not routinely tested. Measurement is not fully standardised across laboratories — different labs use different units and reference ranges. This has made some doctors hesitant to order it without being ready to explain the result clearly.

But deciding not to test is not the same as deciding there is no risk.

Absence of testing is not the same as absence of risk.

At TSquared Health, we do not just ask whether a result looks abnormal. We ask what the data is actually building toward — and what is not yet visible.

The Three Markers That Work Together

Lp(a) rarely acts alone. Understanding your true cardiovascular picture means looking at it alongside the other markers that standard screening leaves out.

When we assessed Julien — lean, athletic, visibly healthy by every external measure – his Lp(a) was elevated. So was his ApoB. And so was his homocysteine. Three different markers. Three different mechanisms. None captured by the panel that had been telling him he was fine for years.

ApoB measures the number of harmful cholesterol particles directly — the particles responsible for building up in artery walls. Your standard LDL reading measures the cholesterol inside those particles. But what actually causes damage is the number of particles, not just the cholesterol load. You can have a normal-looking LDL result while your particle count is high. ApoB sees this. LDL does not. The European Society of Cardiology now recommends ApoB as the primary marker for cardiovascular risk assessment.

Homocysteine is a substance produced during normal metabolic processes. When it is elevated, it is independently associated with artery wall damage and a higher risk of clot formation. Unlike Lp(a), homocysteine responds to targeted nutritional support — specifically B12 status, folate, and the body’s methylation pathways. For most people, levels can come down meaningfully within three to four months. Julien saw that result. His Lp(a) did not move — it cannot be changed through lifestyle. But the overall risk picture shifted significantly.

This is what systems thinking looks like in clinical practice. Not a single number. Not a single intervention. A coherent picture, acted on with precision.

What Elevated Lp(a) Means, and What It Doesn’t

An elevated Lp(a) is not a diagnosis. It is a risk factor. It adds to whatever else is in your cardiovascular picture. It means vigilance. It does not mean inevitability.

Because Lp(a) cannot be reduced through lifestyle or most medications, knowing it is elevated changes how you look at every other modifiable risk factor. LDL becomes more important to manage, not less. ApoB targets become more specific. Blood pressure, inflammation, and blood sugar all become levers worth pulling harder — because they are the levers that actually respond.

Knowing your Lp(a) does not give you more to worry about. It gives you the right frame for managing your heart health. The person who learns their Lp(a) is elevated and responds by optimising everything else is in a significantly better position than the person who never checked and assumes a clean cholesterol result means everything is fine.

Julien now knows. He manages accordingly. The trajectory, while it cannot be changed the way many other markers can, is no longer invisible.

Who Should Measure This

The honest answer: almost everyone should know their Lp(a) at least once.

The European Society of Cardiology recommends measurement at least once in every adult’s lifetime — and earlier for those with a family history of cardiovascular events. Given that roughly 1 in 5 people carries genetically elevated Lp(a), and given that many of them receive clean cholesterol results year after year, this is not over-caution. It is closing a data gap that exists by default for most people.

In practice, the people who need this most are:

• Those with a family history of early cardiovascular events — a parent, sibling, or close relative who had a heart attack, stroke, or arterial disease before age 60. Lp(a) runs in families. If a family member had unexplained heart problems, this is the first question to ask.
• Those who are health-conscious — training, eating well, managing stress — and want to know whether their cardiovascular profile actually reflects that effort. Standard screening often tells this group everything looks fine. That result may be incomplete.
• Those who have received a slightly elevated LDL or borderline ApoB result and want the full picture before deciding how to respond. In the context of elevated Lp(a), those results carry a different weight.

Lp(a) does not vary by nationality or ethnicity in the way some risk factors do. Singapore’s professional community carries the same genetic distribution as the rest of the world.

The Data You Did Not Have

Julien left his first assessment at TSquared Health knowing things he had never been told – despite years of what most would consider exemplary health maintenance.

He was not frightened. He was better oriented.

Within a few months, his homocysteine was back in the healthy range. His cardiovascular strategy was recalibrated. The variables he could influence were being managed precisely. The one variable he could not change – his Lp(a) – was being tracked and contextualised, rather than ignored because no one had thought to test it.

That is what real preventive cardiovascular assessment looks like. Not more tests ordered without reason. A coherent picture that includes what standard screening structurally leaves out — ordered because there is a specific reason to look, interpreted because the interpretation matters, and followed up because the data has somewhere to go.

At TSquared Health, we do not ask whether your cholesterol is abnormal. We ask what your cardiovascular biology is building toward — and whether you have the full picture to act on it.

You don’t know until you look.

TSquared Health is a physician-led longevity diagnostics clinic in Singapore, offering comprehensive biomarker analysis with personal oversight by Dr. Hisham Badaruddin across 170+ markers. MOH-licensed: L/26M2131/MDS/001/262. This article is educational in nature and does not constitute medical advice.